BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24897005)

  • 21. Activating PAX gene family paralogs to complement PAX5 leukemia driver mutations.
    Hart MR; Anderson DJ; Porter CC; Neff T; Levin M; Horwitz MS
    PLoS Genet; 2018 Sep; 14(9):e1007642. PubMed ID: 30216339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sinonasal rhabdomyosarcoma in children and young adults.
    Ahmed AA; Tsokos M
    Int J Surg Pathol; 2007 Apr; 15(2):160-5. PubMed ID: 17478770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sporadic renal hemangioblastoma with CA9, PAX2 and PAX8 expression: diagnostic pitfall in the differential diagnosis from clear cell renal cell carcinoma.
    Kuroda N; Agatsuma Y; Tamura M; Martinek P; Hes O; Michal M
    Int J Clin Exp Pathol; 2015; 8(2):2131-8. PubMed ID: 25973115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of PAX2 immunostaining in tumor diagnosis: a review and update.
    Ordóñez NG
    Adv Anat Pathol; 2012 Nov; 19(6):401-9. PubMed ID: 23060065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significant variation of immunohistochemical marker expression in paired primary and metastatic clear cell renal cell carcinomas.
    Pan Z; Grizzle W; Hameed O
    Am J Clin Pathol; 2013 Sep; 140(3):410-8. PubMed ID: 23955461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [PAX gene function during kidney tumorigenesis: a comparative approach].
    Béland M; Bouchard M
    Bull Cancer; 2006 Sep; 93(9):875-82. PubMed ID: 16980230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic utility of PAX8 and PAX2 immunohistochemistry in the identification of metastatic Müllerian carcinoma in effusions.
    Wiseman W; Michael CW; Roh MH
    Diagn Cytopathol; 2011 Sep; 39(9):651-6. PubMed ID: 20949455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PAX2 and PAX8: useful markers for metastatic effusions.
    Waters L; Crumley S; Truong L; Mody D; Coffey D
    Acta Cytol; 2014; 58(1):60-6. PubMed ID: 24334997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PAX2 and PAX8 expression in primary and metastatic müllerian epithelial tumors: a comprehensive comparison.
    Ozcan A; Liles N; Coffey D; Shen SS; Truong LD
    Am J Surg Pathol; 2011 Dec; 35(12):1837-47. PubMed ID: 21989345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic utility of cyclin D1 in the diagnosis of small round blue cell tumors in children and adolescents.
    Magro G; Salvatorelli L; Alaggio R; D'Agata V; Nicoletti F; Di Cataldo A; Parenti R
    Hum Pathol; 2017 Feb; 60():58-65. PubMed ID: 27984122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lhx1 and Lhx5 maintain the inhibitory-neurotransmitter status of interneurons in the dorsal spinal cord.
    Pillai A; Mansouri A; Behringer R; Westphal H; Goulding M
    Development; 2007 Jan; 134(2):357-66. PubMed ID: 17166926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mouse mesenchymal stem cells expressing PAX-FKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations.
    Ren YX; Finckenstein FG; Abdueva DA; Shahbazian V; Chung B; Weinberg KI; Triche TJ; Shimada H; Anderson MJ
    Cancer Res; 2008 Aug; 68(16):6587-97. PubMed ID: 18701482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical expression of CRX in extracranial malignant small round cell tumors.
    Terry J; Calicchio ML; Rodriguez-Galindo C; Perez-Atayde AR
    Am J Surg Pathol; 2012 Aug; 36(8):1165-9. PubMed ID: 22790857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic Utility of GATA3 and ISL1 in Differentiating Neuroblastoma From Other Pediatric Malignant Small Round Blue Cell Tumors.
    Mohanty SK; Diwaker P; Mishra SK; Jha S; Lobo A; Panda SP; Sharma S; Kumar M; Arora S; Mallik V; Jain D; Jain E; Chakrabarti I; Varshney J; Beg A; Dixit M; Baisakh MR; Naik S; Sahoo SK; Akgul M; Balzer BL; Amin MB; Parwani AV
    Int J Surg Pathol; 2024 Apr; 32(2):294-303. PubMed ID: 37312579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system.
    Carvalho JC; Thomas DG; McHugh JB; Shah RB; Kunju LP
    Histopathology; 2012 Mar; 60(4):597-608. PubMed ID: 22260386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PAX8 Expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors.
    Long KB; Srivastava A; Hirsch MS; Hornick JL
    Am J Surg Pathol; 2010 May; 34(5):723-9. PubMed ID: 20414099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas.
    Davicioni E; Finckenstein FG; Shahbazian V; Buckley JD; Triche TJ; Anderson MJ
    Cancer Res; 2006 Jul; 66(14):6936-46. PubMed ID: 16849537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD31 immunoreactivity in small round cell tumors.
    Nicholson SA; McDermott MB; DeYoung BR; Swanson PE
    Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):19-24. PubMed ID: 10937044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of PAX-8, CD5, and CD117 in distinguishing thymic carcinoma from poorly differentiated lung carcinoma.
    Asirvatham JR; Esposito MJ; Bhuiya TA
    Appl Immunohistochem Mol Morphol; 2014; 22(5):372-6. PubMed ID: 23958552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pax2 and pax8 regulate branching morphogenesis and nephron differentiation in the developing kidney.
    Narlis M; Grote D; Gaitan Y; Boualia SK; Bouchard M
    J Am Soc Nephrol; 2007 Apr; 18(4):1121-9. PubMed ID: 17314325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.